West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on October 23, 2026

Oct. 23, 2026

포트리아와 오미코, 바이오마커 기반 항암 신약 개발 발전 위한 협력 추진

Indeterminate GlobeNewswire

Oct. 23, 2026

Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker

Indeterminate GlobeNewswire

Oct. 23, 2026

Colaboração Entre Fortrea e Omico Impulsiona Desenvolvimento de Medicamentos Oncológicos Guiados por Biomarcadores

Indeterminate GlobeNewswire

Oct. 23, 2026

ความร่วมมือระหว่าง Fortrea และ Omico…

Indeterminate GlobeNewswire

Oct. 23, 2026

Fortrea 与 Omico 携手，推进生物标志物导向的肿瘤药物开发

Indeterminate GlobeNewswire

Oct. 23, 2026

Fortrea 與 Omico 攜手合作，推動生物標記主導的腫瘤藥物開發

Indeterminate GlobeNewswire

Oct. 23, 2026

Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire

Oct. 23, 2026

Das KFSH verkürzt die Wartezeit auf einen Termin für eine Echokardiographie von 126 Tagen auf einen Tag

Indeterminate GlobeNewswire

Oct. 23, 2026

Le KFSH réduit le délai d’attente pour un rendez-vous d’échocardiographie de 126 jours à un seul

Indeterminate GlobeNewswire

Oct. 23, 2026

KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells

Indeterminate GlobeNewswire

Oct. 23, 2026

eClinical Solutions Market to Reach USD 25.22 Billion by 2030, Growing at a CAGR of 13.9% – MarketsandMarkets™

Indeterminate GlobeNewswire

Oct. 23, 2026

GOA Therapeutics Presents New Data at ANESTHESIOLOGY® 2026 for GOA26, a First-in-Class Candidate for Acute Alcohol Intoxication and Poisoning

Indeterminate GlobeNewswire

Oct. 23, 2026

Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

How Peptide Conjugate Developability Is Shaped Before a Candidate Is Nominated

Indeterminate GlobeNewswire

Oct. 23, 2026

Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma

Indeterminate GlobeNewswire

Oct. 23, 2026

Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers

Indeterminate GlobeNewswire

Oct. 23, 2026

MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN

Indeterminate GlobeNewswire

Oct. 23, 2026

Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress

Indeterminate GlobeNewswire

Oct. 23, 2026

Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026

Indeterminate GlobeNewswire